Charlotte Hu
Articles Authored by Charlotte Hu
May 11, 2020
Decipher Bladder Cancer Test Determines Molecular Subtype Most Likely to Respond to Keytruda
The platform was used to subtype patients in a Phase II trial and found that patients in the claudin-low subgroup had the best two-year progression-free survival on pembrolizumab.
Mar 24, 2020
Germline Genetic Testing, Counseling Move Remote as Pandemic Limits In-Person Care Capacity
Many companies and counselors see the COVID-19 pandemic as a catalyst for moving germline risk testing into a digital-first healthcare model.
Jan 8, 2020
CVS Health, Tempus Precision Oncology Program Aims to Aid Oncologists, Improve Patient Outcomes
Premium
The CVS-Tempus partnership aims to streamline the cancer care process for patients from the point of prescribing onwards and connect patients with local trials.